eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
5/2022
vol. 39
 
Share:
Send email
Share:
abstract:
Original paper

Assessment of the post-SARS-CoV-2 vaccination response depending on the epidemiological status, demographic parameters and levels of selected cytokines in medical personnel

Zbigniew Bartuzi
1
,
Tomasz Rosada
1
,
Natalia Ukleja-Sokołowska
1
,
Katarzyna Napiórkowska-Baran
1
,
Kinga Lis
1
,
Magdalena Żbikowska-Gotz
1
,
Wojciech Kowalczyk
1
,
Ewa Szynkiewicz
1
,
Ewa Alska
1
,
Łukasz Cała
1

  1. Department of Allergology, Clinical Immunology and Internal Medicine, Ludwik Rydygier Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Poland
Adv Dermatol Allergol 2022; XXXIX (5): 913-922
DOI: https://doi.org/10.5114/ada.2022.120884
Online publish date: 2022/11/09
View full text Get citation
 
Introduction
SARS-CoV-2 is responsible for causing the COVID-19 disease, which affected 174 million people worldwide. After vaccines were launched, the focus was on their effectiveness and the degree of their safety.

Aim
The authors try to find factors that may affect the response to vaccination.

Material and methods
The study was conducted in 47 adults (39 women and 8 men; age: 47.3 ±11.2). Participants were vaccinated with two doses of the Comirnaty mRNA vaccine. Each patient had a medical history taken and the concentration of specific sIgG antibodies against S1 protein and SARS-CoV-2 N protein, as well as of selected cytokines (IL-8, TGF-b, IFN-g) was determined before and 3 weeks after the first and second dose of the vaccine.

Results
There were 18 convalescents among the respondents. A statistically significant increase in the concentration of specific sIgG S1 in subsequent determinations was observed. Higher levels of sIgG S1 were found after the first dose of the vaccine in COVID-19 convalescents. There was no statistically significant influence of age, body mass index and sex on the increase in the concentration of antibodies and the concentration of the determined cytokines. It was shown that the higher the initial TGF-b concentration, the greater the increase in sIgG S1 after administration of the vaccine.

Conclusions
Vaccination did not increase the levels of IL-8, IFN-g and TGF-b. A higher concentration of serum TGF-b before vaccination correlated with the higher concentration of sIgG S1 antibodies after the first dose of the vaccine.

keywords:

SARS-CoV 2, vaccination, IgG S1, interleukin-8, interferon-g, transforming growth factor-b, COVID 19
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.